HKSE:01099 (China)  
Sinopharm Group Co Ltd logo

Sinopharm Group Co Ltd

HK$ 16.78 (-0.83%) Aug 18
P/E:
5.45
P/B:
0.68
Market Cap:
HK$ 52.80B ($ 6.73B)
Enterprise V:
HK$ 81.48B ($ 10.39B)
Volume:
3.45M
Avg Vol (2M):
3.20M
Also Trade In:
Volume:
3.45M
Market Cap HK$:
52.80B
Market Cap $:
6.73B
PE Ratio:
5.45
Avg Vol (2-Month):
3.20M
Enterprise Value HK$:
81.48B
Enterprise Value $:
10.39B
PB Ratio:
0.68
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Sinopharm Group Co Ltd
NAICS : 325412
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Description
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 76% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Financials (Next Earnings Date:2022-08-23 Est.)

HKSE:01099's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 633,919.512
EPS (TTM) (HK$) 3.03
Beta 1.31
Volatility % 19.52
14-Day RSI 31.12
14-Day ATR (HK$) 0.488716
20-Day SMA (HK$) 17.753
12-1 Month Momentum % -14.21
52-Week Range (HK$) 16.22 - 22.5
Shares Outstanding (Mil) 3,120.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sinopharm Group Co Ltd Filings

Document Form Filing Date
No Filing Data